Chow K, Sommerlad W, Boehrer S, Schneider B, Seipelt G, Rummel M, Hoelzer D, Mitrou P, Weidmann E. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases. Haematologica [Internet]. 2002Jan.1 [cited 2026Nov.7];87(1):33-. Available from: https://haematologica.org/article/view/2234